COMMUNIQUÉS West-GlobeNewswire

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
22/01/2026
SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
22/01/2026
CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
22/01/2026
First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and adolescents with classic CAH SAN DIEGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Crinetics [...]
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
22/01/2026
MINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“ Anteris ” or the “ Company ”) (NASDAQ: AVR , ASX: AVR), a global structural heart company committed to [...]
Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference
22/01/2026
Fourth quarter and full year 2025 investor conference call scheduled for February 25, 2026 at 4:30 p.m. ET Arcutis management to present at the Guggenheim Emerging Outlook: Biotech Summit on February 11, 2026 WESTLAKE [...]
River Oaks Treatment Center Appoints New Clinical Director Amid Expansion of Mental Health Services
22/01/2026
RIVERVIEW, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- River Oaks Treatment Center, a leading addiction rehab center near Tampa, has appointed Brianna Hardcastle, LCSW, as its new Clinical Director as it continues to scale [...]
Intuitive Announces Fourth Quarter Earnings
22/01/2026
SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]
Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution
22/01/2026
Chassieu, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Chassieu (France), 20 January 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB) , industrial greentech specialised in the development of natural microbiological solutions based [...]
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
22/01/2026
4D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to Therapy NEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D Path , a company dedicated to personalizing cancer care through a novel, physics-inspired [...]
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026
22/01/2026
NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“ Psyence BioMed ” or the “ Company ”) today announced that it adjourned its annual and special meeting of shareholders (the “ Meeting [...]
J-Star Files Formal Complaints Against PwC with AICPA and PCAOB
22/01/2026
J-Star’s Complaints Allege PwC Misrepresented Qualifications During J-Star’s IPO, Delaying Process and Resulting in Additional Fees TAICHUNG CITY, Taiwan, Jan. 22, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. ( [...]
LifeLabs Opens New Uptown New Westminster Patient Service Centre, Enhancing Access to Community-Based Diagnostic Care
22/01/2026
New Westminster, BC, Jan. 22, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, has officially opened a new Patient Service Centre (PSC) in Uptown New Westminster, British [...]
OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software
22/01/2026
MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that its high-quality, multimodal clinical [...]
Roji Health Intelligence Re-Certified as CMS Qualified Registry for 2026
22/01/2026
CHICAGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Roji Health Intelligence , a healthcare technology firm focused on value-based care and quality performance, today announced that it has been re-certified as a Centers for [...]
Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker
22/01/2026
Executed in accordance with FDA human factors and usability engineering guidance, the study is intended to de-risk downstream regulatory review and support a streamlined path toward clinical development Raanana, Israel [...]
Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulations and Advanced Biologic Therapies
22/01/2026
New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced the appointment of [...]
Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique
22/01/2026
NEW YORK et SAVONE, Italie, 22 janv. 2026 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui favorise l’ [...]
SPR Announces Eight Featured Posters and Presentations at NANS 2026
22/01/2026
CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American Neuromodulation Society (NANS) [...]
Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials
22/01/2026
HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based solutions through a [...]

Pages